Timothy Richard Maher, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tachycardia, Ventricular | 6 | 2024 | 1270 | 1.780 |
Why?
|
Catheter Ablation | 7 | 2024 | 2671 | 1.140 |
Why?
|
Electrophysiologic Techniques, Cardiac | 3 | 2024 | 485 | 0.840 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2024 | 477 | 0.730 |
Why?
|
Pacemaker, Artificial | 2 | 2024 | 827 | 0.710 |
Why?
|
Cicatrix | 1 | 2024 | 790 | 0.600 |
Why?
|
Prosthesis-Related Infections | 1 | 2023 | 497 | 0.580 |
Why?
|
Cardiomyopathies | 1 | 2022 | 2041 | 0.350 |
Why?
|
Atrial Fibrillation | 5 | 2024 | 5097 | 0.290 |
Why?
|
Pulmonary Veins | 2 | 2024 | 732 | 0.280 |
Why?
|
Electrocardiography | 5 | 2024 | 6378 | 0.240 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2023 | 62 | 0.210 |
Why?
|
Epicardial Mapping | 1 | 2022 | 51 | 0.210 |
Why?
|
Atrioventricular Node | 1 | 2023 | 179 | 0.200 |
Why?
|
Suction | 1 | 2023 | 268 | 0.190 |
Why?
|
Recurrence | 2 | 2024 | 8478 | 0.190 |
Why?
|
Tachycardia, Supraventricular | 1 | 2023 | 265 | 0.180 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2024 | 867 | 0.170 |
Why?
|
Heart Atria | 2 | 2023 | 1350 | 0.170 |
Why?
|
Azithromycin | 1 | 2020 | 201 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2246 | 0.160 |
Why?
|
Heart Rate | 3 | 2024 | 4190 | 0.150 |
Why?
|
Heart Ventricles | 3 | 2024 | 3821 | 0.140 |
Why?
|
Carboxylesterase | 1 | 2016 | 31 | 0.130 |
Why?
|
Action Potentials | 1 | 2024 | 1829 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 427 | 0.130 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 137 | 0.130 |
Why?
|
Long QT Syndrome | 1 | 2020 | 473 | 0.130 |
Why?
|
Patient Selection | 1 | 2022 | 4248 | 0.090 |
Why?
|
Fatty Acids | 1 | 2016 | 1807 | 0.080 |
Why?
|
Epilepsy | 1 | 2023 | 3317 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15390 | 0.070 |
Why?
|
Humans | 16 | 2024 | 766432 | 0.070 |
Why?
|
Middle Aged | 7 | 2024 | 223127 | 0.060 |
Why?
|
Vectorcardiography | 1 | 2024 | 48 | 0.060 |
Why?
|
Paint | 1 | 2023 | 34 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.050 |
Why?
|
Female | 8 | 2024 | 396354 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 65202 | 0.050 |
Why?
|
Male | 7 | 2024 | 363975 | 0.050 |
Why?
|
Aged | 5 | 2024 | 171234 | 0.050 |
Why?
|
Body Temperature | 1 | 2021 | 781 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6543 | 0.030 |
Why?
|
Esters | 1 | 2016 | 212 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2229 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2024 | 1489 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 909 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2016 | 1749 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3919 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81588 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6306 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5583 | 0.020 |
Why?
|
Myocardium | 1 | 2023 | 4763 | 0.020 |
Why?
|
Computer Simulation | 1 | 2023 | 6259 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 24272 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22245 | 0.020 |
Why?
|
Algorithms | 1 | 2023 | 14071 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39283 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40116 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7475 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10812 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8729 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20706 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59538 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41703 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74828 | 0.010 |
Why?
|